Author

Lucas BonDurant

Alnylam Pharmaceuticals (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 1 Organism:human· 1 Approach:statistical model· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

Aimée M. DeatoniD· 1 shared Alexander O. Flynn-Carroll· 1 shared Aris BarasiD· 1 shared Gregory HinkleiD· 1 shared Luca Andrea LottaiD· 1 shared Lucas D. WardiD· 1 shared Margaret M. ParkeriD· 1 shared Parsa AkbariiD· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

Aimée M. DeatonORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Gene-level analysis of rare variants in 363,977 whole exome sequences identifies an association of GIGYF1 loss of function with type 2 diabetes

Aimée M. Deaton, Margaret M. Parker, Lucas D. Ward, Alexander O. Flynn-Carroll, Lucas BonDurant, Gregory Hinkle, Parsa Akbari, Luca Andrea Lotta, Aris Baras, Paul Nioi

The paper identifies GIGYF1 loss of function variants as associated with increased risk of type 2 diabetes and higher glucose/HbA1c levels in a large exome sequencing study.

medRxiv · Jan 19, 2021 · PreprintGenetic & Genomic Medicine